Coverage of the speaker pioneer’s suit highlights shift in the way the general media engages with IP issues
New ranking celebrates the US automaker’s advances in autonomous driving, but there are more obstacles to overcome
There are significant gains for branded pharma in the agreement. But in several other areas, China has made commitments it already meets
Surprise move means Enlarged Board will not now be asked to consider key questions that were referred to it yesterday
The award of $448 million in antitrust damages against the company in case brought by the Federal Trade Commission is also at stake.
Guiding principle behind pre-Christmas statement was need for uniform rules for all patents, Nicholas Matich explained at ABA event, where he also spoke about new agency 101 initiative following SCOTUS refusal to hear key eligibility case
Oral hearings before the EPO’s Boards of Appeal may have a big impact on the European Cas9 landscape
USPTO records show that Big Blue off-loaded hundreds of assets to Xperi late last year in its latest major deal
The Chinese IP office knocked out several claims from the sole patent owned by the NPE that was deemed essential and infringed in a recent Nanjing FRAND ruling
Decision to join follows the acquisition of open source giant Red Hat and is a major boost to the defensive patent operator
Chinese company says patent and trade secrets litigation launched by North Carolina-based Celgard in a US court constitutes "slander of the company’s goodwill"
Decision not to hear Athena dispute will disappoint many, but may prove catalyst to reinvigorate stalled efforts to reform US patent eligibility regime
Apple top defendant again; Eastern District of Texas loses further ground; and other key stats
Medtech leader Masimo accuses tech giant of patent infringement and trade secret theft
Unwired Planet judge rules that ZTE and Huawei infringed two of the NPE’s patents while a third was ruled invalid